192 related articles for article (PubMed ID: 21105876)
1. Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.
Soldati C; Bithell A; Conforti P; Cattaneo E; Buckley NJ
J Neurochem; 2011 Feb; 116(3):415-25. PubMed ID: 21105876
[TBL] [Abstract][Full Text] [Related]
2. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
4. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
Zuccato C; Belyaev N; Conforti P; Ooi L; Tartari M; Papadimou E; MacDonald M; Fossale E; Zeitlin S; Buckley N; Cattaneo E
J Neurosci; 2007 Jun; 27(26):6972-83. PubMed ID: 17596446
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
[TBL] [Abstract][Full Text] [Related]
6. In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.
Conforti P; Mas Monteys A; Zuccato C; Buckley NJ; Davidson B; Cattaneo E
Gene Ther; 2013 Jun; 20(6):678-85. PubMed ID: 23151521
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
9. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
Zuccato C; Tartari M; Crotti A; Goffredo D; Valenza M; Conti L; Cataudella T; Leavitt BR; Hayden MR; Timmusk T; Rigamonti D; Cattaneo E
Nat Genet; 2003 Sep; 35(1):76-83. PubMed ID: 12881722
[TBL] [Abstract][Full Text] [Related]
10. Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.
Desplats PA; Lambert JR; Thomas EA
Neurobiol Dis; 2008 Sep; 31(3):298-308. PubMed ID: 18595722
[TBL] [Abstract][Full Text] [Related]
11. Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones.
Schiffer D; Caldera V; Mellai M; Conforti P; Cattaneo E; Zuccato C
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):899-910. PubMed ID: 24634989
[TBL] [Abstract][Full Text] [Related]
12. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
Zajac MS; Pang TY; Wong N; Weinrich B; Leang LS; Craig JM; Saffery R; Hannan AJ
Hippocampus; 2010 May; 20(5):621-36. PubMed ID: 19499586
[TBL] [Abstract][Full Text] [Related]
13. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.
Johnson R; Buckley NJ
Neuromolecular Med; 2009; 11(3):183-99. PubMed ID: 19458943
[TBL] [Abstract][Full Text] [Related]
14. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of REST by Sp1 in Huntington's disease models.
Ravache M; Weber C; Mérienne K; Trottier Y
PLoS One; 2010 Dec; 5(12):e14311. PubMed ID: 21179468
[TBL] [Abstract][Full Text] [Related]
17. The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington's disease.
Orozco-Díaz R; Sánchez-Álvarez A; Hernández-Hernández JM; Tapia-Ramírez J
PLoS One; 2019; 14(7):e0220393. PubMed ID: 31361762
[TBL] [Abstract][Full Text] [Related]
18. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
[TBL] [Abstract][Full Text] [Related]
19. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.
Boudreau RL; McBride JL; Martins I; Shen S; Xing Y; Carter BJ; Davidson BL
Mol Ther; 2009 Jun; 17(6):1053-63. PubMed ID: 19240687
[TBL] [Abstract][Full Text] [Related]
20. Drug targeting of dysregulated transcription in Huntington's disease.
Kazantsev AG; Hersch SM
Prog Neurobiol; 2007 Nov; 83(4):249-59. PubMed ID: 17379386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
